Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-449319
Filing Date
2012-11-02
Accepted
2012-11-02 17:00:39
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d411937d10q.htm 10-Q 295868
2 EX-31.1 d411937dex311.htm EX-31.1 10205
3 EX-31.2 d411937dex312.htm EX-31.2 10224
4 EX-32.1 d411937dex321.htm EX-32.1 4166
  Complete submission text file 0001193125-12-449319.txt   2158606

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpix-20120930.xml EX-101.INS 230420
6 XBRL TAXONOMY EXTENSION SCHEMA cpix-20120930.xsd EX-101.SCH 20812
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpix-20120930_cal.xml EX-101.CAL 38948
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpix-20120930_def.xml EX-101.DEF 47092
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpix-20120930_lab.xml EX-101.LAB 173533
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpix-20120930_pre.xml EX-101.PRE 127302
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 121177512
SIC: 2834 Pharmaceutical Preparations